229 related articles for article (PubMed ID: 34166991)
1. Cognitive dysfunction in central disorders of hypersomnolence: A systematic review.
Filardi M; D'Anselmo A; Agnoli S; Rubaltelli E; Mastria S; Mangiaruga A; Franceschini C; Pizza F; Corazza GE; Plazzi G
Sleep Med Rev; 2021 Oct; 59():101510. PubMed ID: 34166991
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic Hypersomnia and Kleine-Levin Syndrome: Primary Disorders of Hypersomnolence Beyond Narcolepsy.
Dye TJ
Semin Pediatr Neurol; 2023 Dec; 48():101082. PubMed ID: 38065631
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of central disorders of hypersomnolence with manual and artificial-intelligence-derived polysomnographic measures.
Cesari M; Egger K; Stefani A; Bergmann M; Ibrahim A; Brandauer E; Högl B; Heidbreder A
Sleep; 2023 Feb; 46(2):. PubMed ID: 36455881
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic hypersomnia and Kleine-Levin syndrome.
Arnulf I; Dodet P; Leu-Semenescu S; Maranci JB
Rev Neurol (Paris); 2023 Oct; 179(7):741-754. PubMed ID: 37684104
[TBL] [Abstract][Full Text] [Related]
5. Genetics and epigenetics of rare hypersomnia.
Mogavero MP; DelRosso LM; Bruni O; Salemi M; Salsone M; Novellino F; Zucconi M; Ferini Strambi L; Ferri R
Trends Genet; 2023 May; 39(5):415-429. PubMed ID: 36842900
[TBL] [Abstract][Full Text] [Related]
6. Comorbid parasomnias in narcolepsy and idiopathic hypersomnia: more REM than NREM parasomnias.
Leu-Semenescu S; Maranci JB; Lopez R; Drouot X; Dodet P; Gales A; Groos E; Barateau L; Franco P; Lecendreux M; Dauvilliers Y; Arnulf I
J Clin Sleep Med; 2022 May; 18(5):1355-1364. PubMed ID: 34984974
[TBL] [Abstract][Full Text] [Related]
7. Altered reinforcement learning in Narcolepsy type I and other central disorders of hypersomnolence.
Strauss M; Griffon L; Elbaz M; Arnulf I; Chennaoui M; Léger D
Sleep Med; 2024 Jan; 113():103-110. PubMed ID: 37995471
[TBL] [Abstract][Full Text] [Related]
8. On-the-road driving performance of patients with central disorders of hypersomnolence.
van der Sluiszen NNJJM; Urbanus B; Lammers GJ; Overeem S; Ramaekers JG; Vermeeren A
Traffic Inj Prev; 2021; 22(2):120-126. PubMed ID: 33543997
[TBL] [Abstract][Full Text] [Related]
9. Test-Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence.
Lopez R; Doukkali A; Barateau L; Evangelista E; Chenini S; Jaussent I; Dauvilliers Y
Sleep; 2017 Dec; 40(12):. PubMed ID: 29099966
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid monoamine levels in central disorders of hypersomnolence.
Barateau L; Jaussent I; Roeser J; Ciardiello C; Kilduff TS; Dauvilliers Y
Sleep; 2021 Jul; 44(7):. PubMed ID: 33476396
[TBL] [Abstract][Full Text] [Related]
11. Comparative polysomnography parameters between narcolepsy type 1/type 2 and idiopathic hypersomnia: A systematic review and meta-analysis.
Zhang Y; Ren R; Yang L; Zhang H; Shi Y; Vitiello MV; Tang X; Sanford LD
Sleep Med Rev; 2022 Jun; 63():101610. PubMed ID: 35278894
[TBL] [Abstract][Full Text] [Related]
12. Potential immunological triggers for narcolepsy and idiopathic hypersomnia: Real-world insights on infections and influenza vaccinations.
Gool JK; Zhang Z; Fronczek R; Amesz P; Khatami R; Lammers GJ
Sleep Med; 2024 Apr; 116():105-114. PubMed ID: 38442518
[TBL] [Abstract][Full Text] [Related]
13. Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence.
Maski KP; Colclasure A; Little E; Steinhart E; Scammell TE; Navidi W; Diniz Behn C
Sleep; 2021 Jul; 44(7):. PubMed ID: 33512510
[TBL] [Abstract][Full Text] [Related]
14. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline.
Maski K; Trotti LM; Kotagal S; Robert Auger R; Rowley JA; Hashmi SD; Watson NF
J Clin Sleep Med; 2021 Sep; 17(9):1881-1893. PubMed ID: 34743789
[TBL] [Abstract][Full Text] [Related]
15. Lipocalin-type prostaglandin D synthase levels increase in patients with narcolepsy and idiopathic hypersomnia.
Wang P; Li Q; Dong X; An H; Li J; Zhao L; Yan H; Aritake K; Huang Z; Strohl KP; Urade Y; Zhang J; Han F
Sleep; 2021 Apr; 44(4):. PubMed ID: 33175978
[TBL] [Abstract][Full Text] [Related]
16. Decreased sleep stage transition pattern complexity in narcolepsy type 1.
Ferri R; Pizza F; Vandi S; Iloti M; Plazzi G
Clin Neurophysiol; 2016 Aug; 127(8):2812-2819. PubMed ID: 27417057
[TBL] [Abstract][Full Text] [Related]
17. Specific T-cell activation in peripheral blood and cerebrospinal fluid in central disorders of hypersomnolence.
Lippert J; Young P; Gross C; Meuth SG; Dräger B; Schirmacher A; Heidbreder A
Sleep; 2019 Feb; 42(2):. PubMed ID: 30445542
[TBL] [Abstract][Full Text] [Related]
18. The Perception and Attention Functions test battery as a measure of neurocognitive impairment in patients with suspected central disorders of hypersomnolence.
Ramm M; Jafarpour A; Boentert M; Lojewsky N; Young P; Heidbreder A
J Sleep Res; 2018 Apr; 27(2):273-280. PubMed ID: 28771870
[TBL] [Abstract][Full Text] [Related]
19. The Psychomotor Vigilance Test as a measure of alertness and sleep inertia in people with central disorders of hypersomnolence.
Trotti LM; Saini P; Bremer E; Mariano C; Moron D; Rye DB; Bliwise DL
J Clin Sleep Med; 2022 May; 18(5):1395-1403. PubMed ID: 35040431
[TBL] [Abstract][Full Text] [Related]
20. Disease-specific attention impairment in disorders of chronic excessive daytime sleepiness.
Ramm M; Boentert M; Lojewsky N; Jafarpour A; Young P; Heidbreder A
Sleep Med; 2019 Jan; 53():133-140. PubMed ID: 30508781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
